| Original language | English |
|---|---|
| Pages (from-to) | E6 |
| Journal | International Journal of Cancer |
| Volume | 135 |
| Issue number | 7 |
| DOIs |
|
| State | Published - 1 Oct 2014 |
Erratum: MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer. Int J Cancer. 2014 May 15;134(10):2424-2436 doi: 10.1002/ijc.28566. Epub 2013 Nov 23.
- Y. J. Kim
- , H. S. Choi
- , J. Seo
- , J. Y. Song
- , S. E. Lee
- , M. J. Kwon
- , M. J. Kwon
- , J. Kundu
- , K. Jung
- , E. Oh
- , Y. K. Shin
- , Y. L. Choi
Research output: Contribution to journal › Comment/debate